PROGRAM - INRC

Thursday, June 23, 2011
72 Functional MRI-based support vector machine classification of tobacco smokers’ nicotine
craving: Possible use in real-time neurofeedback
Y. S. Shah 1 , S. J. Peltier 1 , L. Hernandez-Garcia 1 , D. C. Noll 1 , K. L. Phan 1 , J. K. Zubieta 1 ,
M. K. Greenwald 2 , 1 University of Michigan, Ann Arbor, MI, 2 Wayne State University,
Detroit, MI
73 Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking
cessation outcome
Y. Mashhoon 1 , A. C. Janes 1 , J. E. Jensen 1 , A. P. Prescot 1 , G. Pachas 2 , P. F. Renshaw 1 , M. Fava 2 ,
A. E. Evins 2 , M. J. Kaufman 1 , 1 Neuroimaging Center, McLean Hospital | Harvard Medical
School, Belmont, MA, 2 Massachusetts General Hospital | Harvard Medical School,
Boston, MA
74 The effects of nicotine and non-nicotine components of cigarette smoking on cerebral blood flow
M. Addicott 1 , R. Kozink 1 , T. Harshbarger 2 , B. Froeliger 1 , D. Ban 1 , J. Rose 1 , F. J. McClernon 1 ,
1
Psychiatry, Duke Medical Center, Durham, NC, 2 Radiology, Duke Medical Center,
Durham, NC
GENETICS
75 Cocaine-induced changes in prefrontal cortex glutamate receptor expression depend upon
Homer1 and Homer2 proteins
A. W. Ary, B. W. Miller, C. L. McKenna, L. M. Smith, K. K. Szumlinski, Psychology,
University of California, Santa Barbara, Santa Barbara, CA
76 Sway: A new genetic model for diminished cocaine-reinforced behavior
K. Grasing 1 , S. He 1 , Y. Yang 1 , E. Bryda 2 , 1 Substance Abuse Research Laboratory, VA Medical
Center, Kansas City, MO, 2 Veterinary Medicine, University of Missouri, Columbia, MO
77 Dopamine transporter, substance abuse, and sex differences in novelty-seeking
R. Ashare 1 , C. Hodgkinson 2 , M. Enoch 2 , D. Goldman 2 , R. Sinha 1 , 1 Yale University, New
Haven, CT, 2 LNG at NIAAA, Bethesda, MD
78 Compulsive drug-taking behavior: Interaction of specific genetic variants with response to
cocaine vaccine on treatment effectiveness in cocaine dependence
J. A. Lindsay, D. Nielsen, T. R. Kosten, Baylor College of Medicine, Houston, TX
79 Preliminary pharmacogenetic study of treatment for methamphetamine dependence
K. G. Heinzerling, J. McCracken, L. Ray, A. Swanson, S. Shoptaw, UCLA, Los Angeles, CA
80 Genome-wide association study of addiction to smoking and other substances of abuse
M. D. Li 1 , S. G. Yi 1 , J. Z. Ma 2 , 1 Psychiatry and Neurobehavioral Sciences, University of
Virginia, Charlottesville, VA, 2 Public Health Sciences, University of Virginia,
Charlottesville, VA
81 ANKK1 polymorphisms may influence beta2-nicotinic acetylcholine receptor availability in
nonsmokers
K. Cosgrove 1 , B. Yang 1 , I. Esterlis 1 , D. Lee 1 , R. Gadsden 1 , S. Helmbrecht 1 , F. Bois 1 , J. Seibyl 2 ,
G. Tamagnan 2 , J. Staley 1 , J. Gelernter 1 , 1 Psychiatry, Yale University School of Medicine, New
Haven, CT, 2 Institute for Neurodegenerative Disorders, New Haven, CT
82 Learning and memory differences in the dopamine receptor D2 Taq1A & C957T gene SNP
among HIV-positive alcohol abusers
P. Khatavkar 1 , V. Bryant 1 , M. José-Miguez Perez 1 , R. Malow 1 , B. Lerner 1 , J. Dévieux 1 ,
R. Rosenberg 1 , N. Gandhi 2 , M. Nair 2 , 1 Stempel College of Social Work and Public Health,
Florida International University, North Miami, FL, 2 Immunology, Institute of Neuro-Immune
Pharmacology, Florida International University, Miami, FL
115